Mission
Board & Staff
Funding
Annual Reports
Contact Us
Editorials
Research Papers
Testimony
Letters
Media Coverage
Success Stories
Prevention
Indoor Residual Spraying
Insecticide-Treated Nets
Other Methods
Treatment
ACTs & Other Drugs
Malaria in Pregnancy
Co-Infection
Research
Insecticide Research
Drug Research
Vaccine Trials
Malarial Countries
Taxes & Tariffs
Regional Initiatives
Ministries of Health
Ministries of Finance
Donor Programs
Global Fund to Fight AIDS, TB & Malaria
Roll Back Malaria Partnership
World Health Organization
World Bank
UN Children's Fund
US Agency for International Development
Other Agencies
Private Sector
Companies, Foundations & PPPs
Non-Governmental Organizations
Commodities Manufacturers
Drug Safety
Public Health Insecticides
Campaigns
Become An Advocate
Press Releases
Events
Home
»
Browse content by issue
»
Malaria
»
Research
» Drug Research
Drug Research
Resistance to historically effective antimalarial drugs has contributed to the resurgence of malaria across sub-Saharan Africa in the past decade. The recent discovery of parasitic resistance to Artemisinin monotherapies underscores the urgent need for new and more effective antimalarial treatments.
Medicines for Malaria Venture (MMV) is a non-profit organization created to discover, develop and deliver new antimalarial drugs through effective public-private partnerships. MMV does this by providing drug companies with supplmental funding, technical expertise and logistical support. It currently has over 20 new products in the pipeline.
For more information about Drug Research for malaria control, please visit MMV's website.
Must Read
Malaria Keeps Killing Millions
May 16, 2023
GlaxoSmithKline and Medicines For Malaria Venture announce new collaboration to investigate novel antimalarial compounds
January 28, 2024
Newest Malaria Medicine May Be Losing Potency in Asia, WHO Says
October 17, 2023
Certain Combination Therapy Found More Effective For Treating Malaria In African Children
May 28, 2023
Scientists discover new compound that kills drug-resistant malaria
February 12, 2024
AFM Articles
AFM update on recent drug quality studies
August 16, 2023
Medicine that is more placebo than cure
July 12, 2023
Shelving malaria
April 02, 2024
Malaria Drugs Shelf-Life Possibly Much Longer Than Expected
February 26, 2024
Malaria Keeps Killing Millions
May 16, 2023
» more...
News
SA poised to host human trials of malaria drug made in Africa
October 10, 2023
FDA warns of fake malaria medicine
July 24, 2023
Preparing for the inevitable: how do we tackle drug resistant malaria?
July 23, 2023
Africa's Malaria Battle: Fake Drug Pipeline Undercuts Progress
May 29, 2023
Falsified batches of Coartem recently circulating in Western and Central Africa
May 14, 2023
» more...
Research
Travel and fake artesunate: a risky business
September 22, 2023
Anti-infective medicine quality: analysis of basic product quality by approval status and country of manufacture
July 16, 2023
Implementation of basic quality control tests for malaria medicines in Amazon Basin countries: results for the 2005-2010 period
June 15, 2023
Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa
May 22, 2023
Artemisinin-based combination therapy does not measurably reduce human infectiousness to vectors in a setting of intense malaria transmission
April 18, 2023
» more...
Press Releases
DNDi Partners With Pharma, Biotech, Academia, Public Health Institutes & NGOs to Deliver Lifesaving Drugs
June 24, 2023
Scientists discover new compound that kills drug-resistant malaria
February 12, 2024
MissionMore than 4.3 million medicines tested thanks to calculation grids
February 08, 2024
Novartis Institute for Tropical Diseases Inaugurates New Indonesian Research Initiative to Study Dengue fever, Tuberculosis and Malaria
January 25, 2024
Events
No Events found for this issue
Back to Top